Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

ClinicalTrials.gov ID: NCT00880100

Public ClinicalTrials.gov record NCT00880100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Ultrase MT12 in the Control of Steatorrhea in Cystic Fibrosis (CF) and Pancreatic Insufficient (PI) Children Aged 2 to 6 Years Old

Study identification

NCT ID
NCT00880100
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
49 participants

Conditions and interventions

Interventions

  • Ultrase® MT12 Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 6 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
Oct 31, 2009
Completion
Oct 31, 2009
Last update posted
Mar 15, 2017

2009

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
The Children's Hospital Aurora Colorado 80045
University of Michigan Health System Cystic Fibrosis Center Ann Arbor Michigan 48109-0212
Helen DeVos Children's Hospital-Spectrum Health Research Department Grand Rapids Michigan 40503
SUNY Upstate Medical University Syracuse New York 13203
Duke University Medical Center Durham North Carolina 27710
Rainbow Babies and Children's Hospital - Cystic Fibrosis Center Cleveland Ohio 44106
Children's Medical Center of Dayton Dayton Ohio 45404
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Respiratory Diseases of Children and Adolescents Oklahoma City Oklahoma 73112
Pennsylvania State University and the Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15213
Sanford Children's Specialty Clinic Sioux Falls South Dakota 57117-5039
University of Utah Salt Lake City Utah 84108
Virginia Commonwealth University Richmond Virginia 23298
UW Hospital and Clinics Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00880100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00880100 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →